Arbutus Biopharma Corporation
ABUS NASDAQ

ABUS
Arbutus Biopharma Corporation NASDAQ
Trade now
 
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Trade now

Financial statements

The current financial position of Arbutus Biopharma Corporation

Total assets of ABUS for Q1 21 is 146.24M, 6.68% more than the previous Q4 20. And total liabilities decreased by 8.61% in Q1 21 to 32.09M.

Total assets
Total current assets
Total non-current assets
Total liabilities
Total current liabilities
Total non-current liabilities
Total equity
Total liabilities & shareholders' equities
Total debt
Book value per share
Home Stock Screener Forex Screener Crypto Screener Economic Calendar About Chart Features Pricing Refer a friend House Rules Help Center Website & Broker Solutions Widgets Charting Solutions Lightweight Charting Library Blog & News Twitter